InsiderSignalSign in

← Insider buys

David P. Rosenbaum has sold ARDX and made no open-market buys since Mar 2016

Chief Development Officer at Ardelyx, Inc.

SEC CIK 0001611311 · Filings on SEC.gov ↗

$0Bought

$2.3MSold

NoneLast buy

Every filing

22 filings since Mar 2016, newest first

Ardelyx, Inc.

Chief Development Officer

$34K−1.0%Nov 22

Ardelyx, Inc.

Chief Development Officer

$166K−5.0%Nov 8

Ardelyx, Inc.

Chief Development Officer

$162K−5.0%Nov 6

Ardelyx, Inc.

Chief Development Officer

$343K−9.0%Oct 1

Ardelyx, Inc.

Chief Development Officer

$33K−1.0%Sep 16

Ardelyx, Inc.

Chief Development Officer

$42K−1.0%Aug 22

Ardelyx, Inc.

Chief Development Officer

$242K−6.0%Aug 20

Ardelyx, Inc.

Chief Development Officer

$125K−3.0%Jun 5

Ardelyx, Inc.

Chief Development Officer

$55K−1.0%May 23

Ardelyx, Inc.

Chief Development Officer

$48K−1.0%Feb 28

Ardelyx, Inc.

Chief Development Officer

$64K−1.0%Feb 22

Ardelyx, Inc.

Chief Development Officer

$141K−2.0%Feb 9

Ardelyx, Inc.

Chief Development Officer

$199K−6.0%Jan 10

Ardelyx, Inc.

Chief Development Officer

$34K−1.0%Dec 20

Ardelyx, Inc.

Chief Development Officer

$39K−1.0%Dec 15

Ardelyx, Inc.

Chief Development Officer

$105K−4.0%Dec 8

Ardelyx, Inc.

Chief Development Officer

$51K−2.0%Dec 6

Ardelyx, Inc.

Chief Development Officer

$40K−12.0%Jun 8

Ardelyx, Inc.

Chief Development Officer

$40K−2.0%Apr 8

Ardelyx, Inc.

Chief Development Officer

$210K−14.0%Sep 17

Ardelyx, Inc.

SVP, Drug Development

$56K−2.0%Mar 7

Ardelyx, Inc.

SVP, Drug Development

$31K−1.0%Mar 7

Filings come from SEC EDGAR. Not investment advice.